TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
MARTIN-FACKLAM, M., BURHENNE, J., DING, R., FRICKER, R., MIKUS, G., WALTER-SACK, I.,
W.E., 2002. Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid
cremophor EL. Br J Clin Pharmacol. 53: 576–581.
MARZOLINI, C., PAUS, E., BUCLIN, T., KIM, R.B., 2004a. Polymorphisms in human MDR1 (Pglycoprotein):
recent advances and clinical relevance. Clin. Pharmacol. Ther. 75: 13-33.
MCCAFFREY, G., STAATZ, W.D., SANCHEZ-COVARRUBIAS, L., FINCH, J.D., DEMARCO, K.,
LARACUENTE, M.L., RONALDSON, P.T., DAVIS, T.P., 2012. P-glycoprotein trafficking at the
blood-brain barrier altered by peripheral inflammatory hyperalgesia. J Neurochem. 122: 962-
975.
MCDONALD, R.J., WHITE, N.M., 1993. A triple dissociation of memory systems: hippocampus,
amygdala, and dorsal striatum. Behav Neurosci. 107: 3-22.
MERTSCH, K., MAAS, J., 2002. Blood–brain barrier penetration and drug development from an
industrial point of view. Curr. Med. Chem. Central Nerv. Syst. Agents 2: 187–201.
MIKKAICHI, T., SUZUKI, T., TANEMOTO, M., ITO, S., ABE, T., 2004. The organic anion transporter
(OATP) family. Drug Metab Pharmacokinet. 19: 171-179.
MILLER, D.S., 2010. Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain
barrier. Trends Pharmacol.Sci. 31: 246-254.
MILLER, D.S., BAUER, B., HARTZ, A.M., 2008. Modulation of P-glycoprotein at the blood-brain
barrier: opportunities to improve CNS pharmacotherapy. Pharmacol.Rev. 60: 196-209.
MILLER, T. P., GROGAN, T.M., DALTON, W.S., SPIER, C.M., SCHEPER, R.J., SALMON, S.E.,
1991. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug
resistance with chemotherapy plus high-dose verapamil. J Clin Oncol 9: 17-24.
NAKAGAWA, S., DELI, M.A., KAWAGUCHI, H., SHIMIZUDANI, T., SHIMONO, T., KITTEL, A.,
TANAKA, K., NIWA, M., 2009. A new blood–brain barrier model using primary rat brain
endothelial cells, pericytes and astrocytes. Neurochem. Int. 54: 253–263.
NAKAGAWA, S., DELI, M.A., NAKAO, S., HONDA, M., HAYASHI, K., NAKAOKE, R., KATAOKA, Y.,
NIWA, M., 2007. Pericytes from brain microvessels strengthen the barrier integrity in primary
cultures of rat brain endothelial cells. Cell Mol Neurobiol. 27: 687-694.
NALLANI, S.C., GLAUSER, T.A., HARIPARSAD, N., SETCHELL, K., BUCKLEY, D.J., BUCKLEY,
A.R., DESAI, P.B., 2003. Dosedependent induction of Cytochrome P450 (CYP) 3A4 and
activation of pregnane X receptor by topiramate. Epilepsia 44: 1521-1528.
NARANG, V.S., FRAGA, C., KUMAR, N., SHEN, J., THROM, S., STEWART, C.F., WATERS, C.M.,
2008. Dexamethasone increases expression and activity of multidrug resistance transporters
at the rat blood-brain barrier. Am. J. Physiol. Cell. Physiol. 295: C440-450.
NEUMANN, D., 2010. Modulation von Multidrug-Transportern durch Antiepileptika. Diplomarbeit,
Durchführung der Experimente an der Stiftung Tierärztliche Hochschule Hannover.
NERVI, P., LI-BLATTER, X., AANISMAA, P., SEELIG, A., 2010. P-glycoprotein substrate transport
assessed by comparing cellular and vesicular ATPase activity. Biochim Biophys Acta 1798:
515-525.
195